Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
GSK Singapore Announces Additional Supply of Monoclonal Antibody Sotrovimab to the Government of Singapore 2021-12-07 08:00
Innovent Releases Results of a Phase 1 Clinical Study of IBI362, a Dual Glucagon-like Peptide-1 and Glucagon Receptor Agonist in Chinese Patients with Type 2 Diabetes at the International Diabetes Federation Congress 2021 2021-12-07 08:00
Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for a Novel Glucagon-Like Peptide-1 Analogue, GZR18 2021-12-07 05:54
RaySearch receives large RayStation order in China for carbon ion treatment planning 2021-12-07 05:51
Moscow ranked first among European cities in the ranking of innovations against COVID-19 2021-12-07 02:34
Effort to reduce burden of disease in Australia shines spotlight on natural medicine to support liver health 2021-12-07 01:00
Broncus enter into strategic partnership with New Frontier Health Corporation /United Family Healthcare 2021-12-06 21:44
RedHill Biopharma Reports that Opaganib Mechanism Not Impacted by Viral Spike-Protein Mutations, Including Omicron Mutations 2021-12-06 20:01
Innoforce Completes Second Tranche of Series A Financing 2021-12-06 20:00
Donisi Health Named 2021's "Future Unicorn" by E&T Magazine 2021-12-06 18:59
Hummingbird Bioscience Announces First Patient Dosed in Phase 1 Clinical Trial of HMBD-001 in Advanced HER3-Expressing Solid Malignancies 2021-12-06 17:30
IMPACT 2021 R&D Day: Synthetic Lethality Provides a New Platform for Targeted Cancer Therapy 2021-12-06 16:03
Odyssey Announces Agreement to Combine with BenevolentAI 2021-12-06 14:00
Odyssey Announces Agreement to Combine with BenevolentAI 2021-12-06 14:00
Brii Biosciences Included in Hong Kong Stock Connect 2021-12-06 10:54
OMRON and Doctor Anywhere announce collaboration for digitally enhanced remote hypertension and health management program 2021-12-06 10:46
Jacobio Receives IND Approval for Combination Therapy of KRAS G12C and Cetuximab Injection in China 2021-12-06 09:16
Kazia Announces Positive Final Data From Phase II Clinical Study Of Paxalisib In Newly Diagnosed Glioblastoma 2021-12-04 21:00
Henlius' 4th Biologics: Bevacizumab Biosimilar Hanbeitai Approved by National Medical Products Administration 2021-12-04 01:51
I-Mab Announces First Two Patients Dosed in U.S. Phase 2 Combination Trial of Uliledlimab with Atezolizumab in Patients with Selected Advanced Solid Tumors 2021-12-03 21:00
1 309 310 311 312 313 893